Mast cell stabilizing properties of antihistamines

Francesca Levi-Schaffer*, Ron Eliashar

*Corresponding author for this work

Research output: Contribution to journalComment/debate

27 Scopus citations


Histamine is a key mediator of allergic inflammation, primarily through competitive antagonism of binding to H1 receptors. In this issue, Weller and Maurer report that the H1 antagonist desloratadine possesses mast cell-stabilizing properties when challenged in an IgE-dependent or-independent fashion. Thus, desloratadine provides benefits that are independent of H1 receptor binding and based on mast cell stabilization.

Original languageAmerican English
Pages (from-to)2549-2551
Number of pages3
JournalJournal of Investigative Dermatology
Issue number11
StatePublished - Nov 2009

Bibliographical note

Funding Information:
F. Levi-Schaffer is the recipient of grant funds from the Aimwell Charitable Trust (UK), the Israel Science Foundation, and the Israel Ministry of Health. Dr Levi-Schaffer is a member of the David R Bloom Center for Pharmacy and the Dr Adolph and Klara Brettler Center for Research in Molecular Pharmacology and Therapeutics in the School of Pharmacy, the Hebrew University of Jerusalem.


Dive into the research topics of 'Mast cell stabilizing properties of antihistamines'. Together they form a unique fingerprint.

Cite this